Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2)

被引:40
|
作者
Botta, A
Caldarola, S
Vallo, L
Bonifazi, E
Fruci, D
Gullotta, F
Massa, R
Novelli, G
Loreni, F [1 ]
机构
[1] Univ Roma Tor Vergata, Dept Biol, Rome, Italy
[2] Univ Roma Tor Vergata, Dept Biopathol, Rome, Italy
[3] Bambino Gesu Pediat Hosp, Res Ctr, Rome, Italy
[4] Tor Vergata Hosp, Serv Med Genet, Rome, Italy
[5] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy
关键词
myotonic dystrophy; DM2; CCTG expansion; ZNF9; expression; splicing isoform;
D O I
10.1016/j.bbadis.2005.11.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myotonic dystrophy is caused by two different mutations: a (CTG)(n) expansion in 3' UTR region of the DMPK gene (DM1) and a (CCTG)(n) expansion in intron 1 of the ZNF9 gene (DM2). The most accredited mechanism for DM pathogenesis is an RNA gain-of-function. Other findings suggest a contributory role of DMPK-insufficiency in DM2. To address the issue of ZNF9 role in DM2. we have analyzed the effects of (CCTG)(n) expansion on ZNF9 expression in lymphoblastoid cell lines (n = 4) from DM2 patients. We did not observe any significant alteration in ZNF9 mRNA and protein levels, as shown by QRT-PCR and Western blot analyses. Additional RT-PCR experiments demonstrated that ZNF9 pre-mRNA splicing pattern, which includes two isoforms, is unmodified in DM2 cells. Our results indicate that the (CCTG)(n) expansion in the ZNF9 intron does not appear to have a direct consequence on the expression of the gene itself. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:329 / 334
页数:6
相关论文
共 50 条
  • [1] The myotonic dystrophy type 2 (DM2) CCTG expansion does not prevent allele specific ZNF9 expression
    Malikowski, JM
    Moseley, ML
    Mosemiller, AK
    Jin, D
    Schoser, B
    Kress, W
    Ricker, K
    Day, JW
    Ranum, LPW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 584 - 584
  • [2] The myotonic dystrophy type 2 (DM2) CCTG expansion does not reduce ZNF9 transcript levels or prevent splicing.
    Ranum, LPW
    Moseley, ML
    Jin, DD
    Liquori, CL
    Day, JW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 502 - 502
  • [3] Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9
    Liquori, CL
    Ricker, K
    Moseley, ML
    Jacobsen, JF
    Kress, W
    Naylor, SL
    Day, JW
    Ranum, LPW
    [J]. SCIENCE, 2001, 293 (5531) : 864 - 867
  • [4] Mutant (CCTG)n Expansion Causes Abnormal Expression of Zinc Finger Protein 9 (ZNF9) in Myotonic Dystrophy Type 2
    Raheem, Olayinka
    Olufemi, Shodimu Emmanuel
    Bachinski, Linda L.
    Vihola, Anna
    Sirito, Mario
    Hampf, Jeanette Holmlund
    Haapasalo, Hannu
    Li, Yi Ping
    Udd, Bjarne
    Krahe, Ralf
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 177 (06): : 3025 - 3036
  • [5] Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population
    Vallo, L
    Bonifazi, E
    Borgiani, P
    Novelli, G
    Botta, A
    [J]. MOLECULAR AND CELLULAR PROBES, 2005, 19 (01) : 71 - 74
  • [6] The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles
    Massa, R.
    Panico, M. B.
    Caldarola, S.
    Fusco, F. R.
    Sabatelli, P.
    Terracciano, C.
    Botta, A.
    Novelli, G.
    Bernardi, G.
    Loreni, F.
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2010, 36 (04) : 275 - 284
  • [7] Myotonic dystrophy type 2 is caused by a CCTG expansion in intron 1 of ZNF9.
    Ranum, LPW
    Liquori, CL
    Moseley, ML
    Jacobsen, JF
    Phillips, AV
    Savkur, R
    Kress, W
    Naylor, SL
    Cooper, TA
    Ricker, K
    Day, JW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 211 - 211
  • [8] Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy
    Cardani, R
    Mancinelli, E
    Sansone, V
    Rotondo, G
    Meola, G
    [J]. EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2004, 48 (04): : 437 - 442
  • [9] New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2)
    Sallinen, R
    Vihola, A
    Bachinski, LL
    Huoponen, K
    Haapasalo, H
    Hackman, P
    Zhang, S
    Sirito, M
    Kalimo, H
    Meola, G
    Horelli-Kuitunen, N
    Wessman, M
    Krahe, R
    Udd, B
    [J]. NEUROMUSCULAR DISORDERS, 2004, 14 (04) : 274 - 283
  • [10] Evolutionary conservation of the myotonic dystrophy type 2 (DM2) repeat tract
    Liquori, CL
    Day, JW
    Ranum, LPW
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 325 - 325